Order Article Reprints

Joseph SC, Eugin Simon S, Bohm MS, Kim M, Pye ME, Simmons BW, Graves DG, Thomas-Gooch SM, Tanveer UA, Holt JR, et al. FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers. 2024; 16(7):1368. https://doi.org/10.3390/cancers16071368

Joseph, Sydney C., Samson Eugin Simon, Margaret S. Bohm, Minjeong Kim, Madeline E. Pye, Boston W. Simmons, Dillon G. Graves, Stacey M. Thomas-Gooch, Ubaid A. Tanveer, Jeremiah R. Holt, and et al. 2024. "FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden" Cancers 16, no. 7: 1368. https://doi.org/10.3390/cancers16071368

Joseph, S. C., Eugin Simon, S., Bohm, M. S., Kim, M., Pye, M. E., Simmons, B. W., Graves, D. G., Thomas-Gooch, S. M., Tanveer, U. A., Holt, J. R., Ponnusamy, S., Sipe, L. M., Hayes, D. N., Cook, K. L., Narayanan, R., Pierre, J. F., & Makowski, L. (2024). FXR Agonism with Bile Acid Mimetic Reduces Pre-Clinical Triple-Negative Breast Cancer Burden. Cancers, 16(7), 1368. https://doi.org/10.3390/cancers16071368